The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
SAB Biotherapeutics Inc
NASDAQ:SABS
|
US |
|
Summerset Group Holdings Ltd
NZX:SUM
|
NZ |
|
Hanma Technology Group Co Ltd
SSE:600375
|
CN |
|
A
|
Aristocrat Leisure Ltd
F:AC8
|
AU |
|
A
|
Abercrombie & Fitch Co
XMUN:AFT
|
US |
|
Oriental Land Co Ltd
OTC:OLCLF
|
JP |
|
Maps SpA
MIL:MAPS
|
IT |
|
Four Corners Property Trust Inc
F:4Z1
|
US |
|
Compagnie Financiere Richemont SA
SIX:CFR
|
CH |
|
Y
|
Yum! Brands Inc
DUS:TGR
|
US |
|
N
|
Norfolk Southern Corp
F:NFS
|
US |
|
C
|
China Literature Ltd
SWB:C2X
|
CN |
|
Banca Mediolanum SpA
F:ME1
|
IT |
|
A
|
AB Science SA
SWB:A8D
|
FR |
|
W
|
Wise Group PLC
NASDAQ:WSE
|
UK |
|
S
|
Sega Sammy Holdings Inc
OTC:SGAMF
|
JP |
|
R
|
Ryder System Inc
DUS:RYD
|
US |
|
E
|
Eastgroup Properties Inc
F:EGO
|
US |
|
Bridgestone Corp
OTC:BRDCY
|
JP |
|
Nippon Care Supply Co Ltd
OTC:NYLPF
|
JP |
|
Bemax Inc
OTC:BMXC
|
US |
|
Sumitomo Electric Industries Ltd
OTC:SMTOF
|
JP |
|
Kitron ASA
OSE:KIT
|
NO |
|
S
|
Secom Co Ltd
DUS:XSC
|
JP |
SAB Biotherapeutics Inc (SABS)’s 12-month stock price forecast through October 2027 has a consensus target of $12.24, implying 283% upside. The forecast is based on price targets from 13 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for SABS is 12.24 USD with a low forecast of 6.06 USD and a high forecast of 16.8 USD.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more